[Fabry disease: new clinical research--current therapeutic perspectives]

Wien Klin Wochenschr. 2003 Apr 30;115(7-8):215-7. doi: 10.1007/BF03040318.
[Article in German]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Chromosomes, Human, X
  • Clinical Trials as Topic
  • Diagnosis, Differential
  • Drug Approval
  • Fabry Disease / diagnosis
  • Fabry Disease / drug therapy*
  • Fabry Disease / genetics
  • Female
  • Genes, Recessive / genetics
  • Genetic Carrier Screening
  • Humans
  • Isoenzymes / adverse effects
  • Isoenzymes / therapeutic use*
  • Male
  • Phenotype
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Sex Chromosome Aberrations
  • alpha-Galactosidase / adverse effects
  • alpha-Galactosidase / therapeutic use*

Substances

  • Isoenzymes
  • Recombinant Proteins
  • alpha-Galactosidase
  • agalsidase beta